Ganciclovir
Cytovene, Ganzyk-rtu, Vitrasert, Zirgan (ganciclovir) is a small molecule pharmaceutical. Ganciclovir was first approved as Cytovene on 1994-12-22. It is used to treat aids-related opportunistic infections, cytomegalovirus infections, and cytomegalovirus retinitis in the USA. Cytovene iv's patent is valid until 2034-09-02 (FDA).
| Trade Name | Cytovene, Ganzyk-rtu, Vitrasert, Zirgan |
|---|---|
| Common Name | Ganciclovir |
| Indication | aids-related opportunistic infections, cytomegalovirus infections, cytomegalovirus retinitis |
| Drug Class | Antivirals: antivirals (acyclovir type) |
